This article is part of the supplement: Abstracts of the 11th Annual SCMR Scientific Sessions - 2008 .

Meeting abstract

1056 Feasibility and ultility of cardiac MRI in patients with valved bovine jugular vein conduits for right ventricular outflow tract reconstruction

Sabeena Ramrakhiani¹, Mervyn D Cohen², John W Brown³ and Tiffanie R Johnson⁴

¹Krannert Institute of Cardiology, Indianapolis, IN, USA

²Department of Radiology, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN, USA

³Department of Cardiothoracic Surgery, Indiana University School of Medicine, Indianapolis, IN, USA

⁴Indiana University, Riley hospital for Children, Section of Pediatric Cardiology, Indianapolis, IN, USA

corresponding author email

from 11^th Annual SCMR Scientific Sessions
Los Angeles, CA, USA. 1–3 February 2008

Journal of Cardiovascular Magnetic Resonance 2008, 10(Suppl 1):A181doi:10.1186/1532-429X-10-S1-A181

Published:	22 October 2008

First paragraph (this article has no abstract)

Pulmonary homografts have been the most widely used valved conduits for right ventricular outflow tract (RVOT) reconstruction in the US since mid 1980s. In 1999 a conduit containing a bovine jugular vein (Contegra^®, Medtronic, Inc, Minneapolis, MN) was introduced as a potential alternative for RVOT reconstruction. In 2003, the bovine jugular vein conduit was released by the FDA for humanitarian device exemption (HDE) utilization in centers that obtain institutional review board approval and have appropriate informed patient consent. Main advantages of the Contegra^® conduit include availability in sizes from 12–22 mm, natural continuity between the valve and the conduit that allows proximal infundibular shaping without additional materials, lower price compared to about half of the pulmonary homografts in the US, and reduced potential risk of supravalvular stenosis due to narrowing at the distal suture line. This data has been reported based on echocardiographic findings of the Contegra^® conduit postoperatively. We report on the use of cardiac magnetic resonance (CMR) in patients postoperatively and compare the findings with echocardiography.